US2015018747A1PendingUtilityA1

Methods and compositions to treat myocardial conditions

Assignee: ABBOTT CARDIOVASCULAR SYSTEMSPriority: Apr 15, 2003Filed: Jun 20, 2014Published: Jan 15, 2015
Est. expiryApr 15, 2023(expired)· nominal 20-yr term from priority
A61P 43/00A61P 9/10A61P 7/04A61P 9/04A61P 9/14A61P 7/02A61K 31/728A61K 47/60A61K 49/0404A61L 24/043A61K 41/0042A61K 38/1825A61K 38/1858A61K 31/732A61K 31/79A61K 36/886A61L 2430/20A61K 31/00A61K 31/78A61K 47/34A61K 38/40A61K 38/1841A61L 27/50A61N 1/3625A61K 45/06A61K 31/734A61K 47/62A61K 9/0024A61K 38/18A61L 27/20A61L 27/54A61K 38/1891A61N 1/36521A61K 38/1866A61K 35/34
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle using a combination of therapies. The method may include the introduction of structurally reinforcing agents. In other embodiments, agents may be introduced into a ventricle to increase compliance of the ventricle. The prevention of remodeling may include the prevention of thinning of the ventricular infarct zone. Another embodiment includes the reversing or prevention of ventricular remodeling with electro-stimulatory therapy. The unloading of the stressed myocardium over time effects reversal of undesirable ventricular remodeling. These therapies may be combined with structurally reinforcing therapies. In other embodiments, the structurally reinforcing component may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method to minimize post-infarct ventricular remodeling, comprising:
 delivering electrical stimulation using one or more sensing channels for sensing intrinsic cardiac activity selected from the group consisting of: (i) a plurality of pacing channels for delivering pacing pulses; (ii) a controller for controlling the delivery of pacing pulses in accordance with a pacing algorithm; and (iii) a patch having a plurality of pacing electrodes incorporated into the pacing channels; and   delivering at least one structurally reinforcing component to the infarct region.   
     
     
         2 . The method of  claim 1 , further comprising, a drug delivery system for delivering an agent selected from a group consisting of an ACE inhibitor, a beta blocker, a growth factor, and an anti-apoptotic factor. 
     
     
         3 . The method of  claim 1 , further comprising, an impedance sensor for detecting changes in wall motion and wall thickness in an area in proximity to the infarct and wherein the controller is programmed to modify the delivery of pacing pulses. 
     
     
         4 . The method of  claim 1  wherein delivering at least one structurally reinforcing agent increases the modulus of elasticity of the infarct region. 
     
     
         5 . The method of  claim 1  wherein delivering at least one structurally reinforcing agent to the infarct region comprises delivering microspheres. 
     
     
         6 . The method of  claim 1  wherein the structurally reinforcing agent comprises a modified and/or unmodified alginate gel material.

Join the waitlist — get patent alerts

Track US2015018747A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.